microdosing glp 1 for longevity GLP-1: A Next-Generation Approach to Metabolic and Medicine: Shamsah Amersi, MD: OB-GYNs Microdosing GLP-1 in Miami Beach

Commonly recognized side effects, such as gastrointestinal symptoms, were also widely reported, lending credibility to the approach

The real answer is, "it depends." It depends on your technique, your storage, your diluent, and even the initial purity of the peptide itself

We call this the Price-Safety Trap, the gap between cost and confidence

Higher weekly doses were associated with greater average percentage body weight loss, providing a strong rationale for the slow titration to the highest tolerated maintenance dose

The 0.3% pancreatitis rate in trials, while low, represents a real concern for those with prior episodes

This makes it different from semaglutide (which mimics GLP-1) and tirzepatide (which mimics GLP-1 and GIP)